109 related articles for article (PubMed ID: 16634524)
1. Isolation of human myeloid dendritic cells from tumor tissue and peripheral blood.
Brocks C; Graefe H; Frenzel H; Pries R; Wollenberg B
In Vivo; 2006; 20(2):239-42. PubMed ID: 16634524
[TBL] [Abstract][Full Text] [Related]
2. Functional alteration of myeloid dendritic cells through head and neck cancer.
Brocks CP; Pries R; Frenzel H; Ernst M; Schlenke P; Wollenberg B
Anticancer Res; 2007; 27(2):817-24. PubMed ID: 17465207
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor interference in myeloid dendritic cells through head and neck cancer.
Frenzel H; Hoffmann B; Brocks C; Schlenke P; Pries R; Wollenberg B
Anticancer Res; 2006; 26(6B):4409-13. PubMed ID: 17201162
[TBL] [Abstract][Full Text] [Related]
4. Decreased migration of myeloid dendritic cells through increased levels of C-reactive protein.
Frenzel H; Pries R; Brocks CP; Jabs WJ; Wittkopf N; Wollenberg B
Anticancer Res; 2007; 27(6B):4111-5. PubMed ID: 18225580
[TBL] [Abstract][Full Text] [Related]
5. Immunomagnetic selection of functional dendritic cells from human lymph nodes.
Boor PP; Ijzermans JN; van der Molen RG; Binda R; Mancham S; Metselaar HJ; Kusters JG; de Jong E; Drexhage HA; Kwekkeboom J
Immunol Lett; 2005 Jul; 99(2):162-8. PubMed ID: 16009266
[TBL] [Abstract][Full Text] [Related]
6. Head and neck cancer triggers increased IL-6 production of CD34+ stem cells from human cord blood.
Nitsch SM; Pries R; Wollenberg B
In Vivo; 2007; 21(3):493-8. PubMed ID: 17591359
[TBL] [Abstract][Full Text] [Related]
7. Effect of head and neck cancer supernatant and CpG-oligonucleotides on migration and IFN-alpha production of plasmacytoid dendritic cells.
Thiel A; Pries R; Jeske S; Trenkle T; Wollenberg B
Anticancer Res; 2009 Aug; 29(8):3019-25. PubMed ID: 19661310
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood manipulation significantly affects the result of dendritic cell monitoring.
Gerrits JH; Athanassopoulos P; Vaessen LM; Klepper M; Weimar W; van Besouw NM
Transpl Immunol; 2007 Apr; 17(3):169-77. PubMed ID: 17331843
[TBL] [Abstract][Full Text] [Related]
9. Decreased levels of circulating regulatory NK cells in patients with head and neck cancer throughout all tumor stages.
Wulff S; Pries R; Börngen K; Trenkle T; Wollenberg B
Anticancer Res; 2009 Aug; 29(8):3053-7. PubMed ID: 19661315
[TBL] [Abstract][Full Text] [Related]
10. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression.
Jin O; Kavikondala S; Sun L; Fu R; Mok MY; Chan A; Yeung J; Lau CS
Lupus; 2008 Jul; 17(7):654-62. PubMed ID: 18625638
[TBL] [Abstract][Full Text] [Related]
11. Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial.
Van Driessche A; Van de Velde AL; Nijs G; Braeckman T; Stein B; De Vries JM; Berneman ZN; Van Tendeloo VF
Cytotherapy; 2009; 11(5):653-68. PubMed ID: 19530029
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric techniques for studying plasmacytoid dendritic cells in mixed populations.
Olshalsky SL; Fitzgerald-Bocarsly P
Methods Mol Med; 2005; 116():183-94. PubMed ID: 16000862
[TBL] [Abstract][Full Text] [Related]
13. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.
Pries R; Witrkopf N; Trenkle T; Nitsch SM; Wollenberg B
In Vivo; 2008; 22(1):89-92. PubMed ID: 18396788
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis of peripheral blood dendritic cells in patients with severe sepsis.
Riccardi F; Della Porta MG; Rovati B; Casazza A; Radolovich D; De Amici M; Danova M; Langer M
Cytometry B Clin Cytom; 2011 Jan; 80(1):14-21. PubMed ID: 20687203
[TBL] [Abstract][Full Text] [Related]
15. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
16. A simple density gradient for enriching subfractions of solid tumor cells.
Walle A; Kodama T; Melamed MR
Cytometry; 1983 May; 3(6):402-7. PubMed ID: 6189679
[TBL] [Abstract][Full Text] [Related]
17. A flow cytometric method for determination of absolute counts of myeloid precursor dendritic cells in peripheral blood.
Ma L; Scheers W; Vandenberghe P
J Immunol Methods; 2004 Feb; 285(2):215-21. PubMed ID: 14980435
[TBL] [Abstract][Full Text] [Related]
18. Single-cell observation of phagocytosis by human blood dendritic cells.
Ishimoto H; Yanagihara K; Araki N; Mukae H; Sakamoto N; Izumikawa K; Seki M; Miyazaki Y; Hirakata Y; Mizuta Y; Yasuda K; Kohno S
Jpn J Infect Dis; 2008 Jul; 61(4):294-7. PubMed ID: 18653972
[TBL] [Abstract][Full Text] [Related]
19. Decrease in circulating myeloid dendritic cell precursors in coronary artery disease.
Yilmaz A; Weber J; Cicha I; Stumpf C; Klein M; Raithel D; Daniel WG; Garlichs CD
J Am Coll Cardiol; 2006 Jul; 48(1):70-80. PubMed ID: 16814651
[TBL] [Abstract][Full Text] [Related]
20. Poly(I:C) and lipopolysaccharide innate sensing functions of circulating human myeloid dendritic cells are affected in vivo in hepatitis C virus-infected patients.
Rodrigue-Gervais IG; Jouan L; Beaulé G; Sauvé D; Bruneau J; Willems B; Sékaly RP; Lamarre D
J Virol; 2007 Jun; 81(11):5537-46. PubMed ID: 17376921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
